• No se han encontrado resultados

Prognostic ability of BCLC B Subclassification in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization

N/A
N/A
Protected

Academic year: 2020

Share "Prognostic ability of BCLC B Subclassification in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization"

Copied!
9
0
0

Texto completo

Loading

Figure

Figure 1. Figure 1. Figure 1. Figure 1.
Table 2. Baseline predictors of survival in 289 patients with BCLC-B hepatocellular carcinoma at time of first TACE.
Figure 2.Figure 2.Figure 2.Figure 2.
Figure 3.  Figure 3. Survival probability according to BCLC-B subclassification. A.  A

Referencias

Documento similar

Culture of cCSC was successful in five out of thirty- three patients, mostly using negative enrichment of CD45 − cells, ultra-low adherence, high glucose, and a short period of

The main objective of this study was to determine whether the use of TXA in patients undergoing primary or revision TKR with a history of coronary artery disease increased

Objective: The main purpose of our study was to describe the factors associated with more severe pain levels in a cohort of patients with plantar fasciitis (PF).. The secondary

Venous thrombotic events in patients treated with immune checkpoint inhibitors for non-small cell lung cancer: a retrospective multicentric cohort study. Sussman TA, Li H, Hobbs

The assessment of perceived health status in patients with chronic diseases is essential for measuring the impact and burden of disease, as in the case of patients with

In this large cohort study focusing on the effects of intubation timing in patients with COVID-19, we identified a higher risk of hospital mortality in those individuals with

11 Figure S4 Kaplan-Meier estimates of progression-free survival (A) and overall survival (B) according to tumour sidedness in patients with BRAF- and/or PIK3CA mutations (n=44)...

Kaplan–Meier disease-specific survival curves categorized by active SRC expression (A–C) or nuclear p-SRC (Tyr419) (D–F) in the total cohort of HNSCC patients or in the laryngeal